<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Most <z:e sem="disease" ids="C0001618" disease_type="Neoplastic Process" abbrv="">adrenocortical tumors</z:e> are benign, unilateral, <z:hpo ids='HP_0008256'>adrenocortical adenomas</z:hpo> that are often discovered incidentally </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0346402" disease_type="Neoplastic Process" abbrv="">Adrenocortical cancer</z:e> is rare </plain></SENT>
<SENT sid="2" pm="."><plain>Exceptionally, <z:e sem="disease" ids="C0001618" disease_type="Neoplastic Process" abbrv="">adrenocortical tumors</z:e> can be bilateral </plain></SENT>
<SENT sid="3" pm="."><plain>Although most <z:e sem="disease" ids="C0001618" disease_type="Neoplastic Process" abbrv="">adrenocortical tumors</z:e> occur sporadically, they may also feature in congenital and/or <z:e sem="disease" ids="C0277558" disease_type="Disease or Syndrome" abbrv="">familial disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The identification of germline genetic defects in <z:e sem="disease" ids="C0277558" disease_type="Disease or Syndrome" abbrv="">familial diseases</z:e> associated with <z:e sem="disease" ids="C0001618" disease_type="Neoplastic Process" abbrv="">adrenocortical tumors</z:e> helped to define the somatic alterations in <z:hpo ids='HP_0003745'>sporadic</z:hpo> disease: for example, overexpression of insulin-like growth factor 2 and alterations at the 11p15 locus (observed in <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>) are also found in most <z:e sem="disease" ids="C0346402" disease_type="Neoplastic Process" abbrv="">adrenocortical cancers</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Similarly, inactivating mutations of the TP53 gene, located at 17p13 (observed in <z:e sem="disease" ids="C0085390" disease_type="Neoplastic Process" abbrv="LFS">Li-Fraumeni syndrome</z:e>), can also be found at the somatic level in <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C0346402" disease_type="Neoplastic Process" abbrv="">adrenocortical cancers</z:e>, as can 17p13 allelic losses </plain></SENT>
<SENT sid="6" pm="."><plain>Components of the cyclic <z:chebi fb="47" ids="16027,28971">AMP</z:chebi> signaling pathway--for example, adrenocorticotropic hormone receptors and other membrane receptors, Gs proteins and protein kinase A--can be altered to various degrees in <z:e sem="disease" ids="C0001618" disease_type="Neoplastic Process" abbrv="">adrenocortical tumors</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>More recently, gene profiling and genetic studies have shown that the Wnt-beta-catenin signaling pathway is frequently activated in <z:e sem="disease" ids="C0001618" disease_type="Neoplastic Process" abbrv="">adrenocortical tumors</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>These research findings already have profound implications for clinical management of patients with <z:e sem="disease" ids="C0001618" disease_type="Neoplastic Process" abbrv="">adrenocortical tumors</z:e>, for example in unraveling the genetic origin of the disease in some patients, and in the development of molecular markers for diagnosis and prognosis </plain></SENT>
<SENT sid="9" pm="."><plain>The new findings should also help in the development of new therapeutic options </plain></SENT>
</text></document>